Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-05-10
2000-07-04
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514894, 530828, A61K 3808
Patent
active
060839155
ABSTRACT:
A method of treating liver cancer involving administration to the subject a therapeutically effective amount of a bombesin analog.
REFERENCES:
patent: 5068222 (1991-11-01), Camble et al.
patent: 5081107 (1992-01-01), Cotton et al.
Per O.Seglen, et al., Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours, Carcinogenesis, vol. 10, No. 1, pp. 21-25, 1989.
J of Biol Chem., vol. 262, No. 34, pp. 16456-16460, 1987, Heikkila et al.
Cancer Research, Alexander et al., Effects of Bombesin on Growth of Human Small Cell Lung Carcinoma In Vivo., vol. 48, pp. 1439-1441 (1988).
S. M. Kaftan et al., "Bombesin and Hepatocyte Proliferation", Chemical Carcinogenesis 2 Modulating Factors pp. 619-623, 1989.
Bogden Arthur E.
Coy David H.
Kim Sun Hyuk
Moreau Jacques-Pierre
Biomeasure Inc.
McGowan William F.
Moezie F. T.
Plunkett Dinc
The Administration of the Tulane Educational Fund
LandOfFree
Method for treating liver cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating liver cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating liver cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486632